Selective use of contemporary drug-eluting stents in primary angioplasty for ST-elevation myocardial infarction: pooled analysis of COMFORTABLE AMI and EXAMINATION

EuroIntervention 2017;12:1577-1586 published online October 2016. DOI: 10.4244/EIJ-D-15-00408

Andreas Baumbach
Andreas Baumbach1*, MD; Dik Heg2, PhD; Lorenz Räber3, MD; Miodrag Ostoijc4, MD; Salvatore Brugaletta5, MD, PhD; Julian W. Strange1, MD; Thomas W. Johnson1, MD; Peter Jüni2, MD; Thomas Engstrøm6, MD; Patrick W. Serruys7, MD, PhD; Manel Sabaté5, MD, PhD; Stephan Windecker2, MD
1. Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom; 2. CTU Bern, Department of Clinical Research, and Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; 3. Departm

Aims: Selective use of DES only in patients at higher risk of MACE is common practice, particularly in healthcare systems with a large premium payable for DES. We aimed to identify subgro

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

drug-eluting stentsprimary angioplastystemi
Coronary interventionsSTEMITools, devices and techniques
Read next article
A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)

Latest news